Maravai LifeSciences Holdings, Inc. MRVI Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s noncontrolling interests in subsidiaries?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported noncontrolling interests in subsidiaries of $157.52M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s noncontrolling interests in subsidiaries changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s noncontrolling interests in subsidiaries decreased by 31.4% year-over-year, from $229.66M to $157.52M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s noncontrolling interests in subsidiaries has grown at a 19.3% compound annual growth rate (CAGR), from $66.24M to $160.33M.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.